Onward and Upward , MPL vs Covid Trial Results Pending .....

With Trialing underway at Leiden University of MPL vs Covid / SARs seems a few are growing nervous..

For me the Leiden data will confirm the previous 3 trials carried out, the chances of the 4th trial contradicting the previous 3 is remote.

Had the WEHI data been grey or indecipherable I might have a concern , but from a 50% reduction in Viral Load in the first 24 hrs and 95% in the ensuing 72hrs , I have faith in professionals like Marc Pelligrini and WEHI are commercially neutral, ( no gain hinged to positive or negative results)


Leiden have already identified Anti-Viral Activity with MPL vs SARs https://stocknessmonster.com/announcements/paa.asx-6A1027476/

Leiden University Testing Indicates Monepantel and Monepantel Sulphone SARS-CoV-2 Antiviral Activity
• Previously PAA reported to shareholders that monepantel (MPL) and monepantel sulfone (MPLS) demonstrate antiviral activity in cultured cell infection models of SARSCoV-2, the virus causing COVID-19
• Leiden University Medical Center (LUMC) has generated indicative data that MPL and MPLS again demonstrate antiviral activity in non-human primate systems
• High insolubility of MPL in these systems was challenging and required several analyses
• LUMC is now moving forward and transitioning to human cultured cells

You may have noted another Biotech announced today they have enrolled their first patient for a Human Trial (non Cov) The SP has risen by 30%+ today , the Market responds to Scientific Progress..... and Human Trials are a Huge Catalyst down this end of the Street, it lends credibility and confidence in the Companys ability to bring a Treatment from the Dish to a Patient..

I feel when Leiden push the media button on MPL vs Cov /SARs results Pharmaust better have pen and paper at the ready.....

For those that have been in Biotech over the past several years are aware that Big Pharma have reduced in-house R and D in the Billions choosing to Opportunity scan for near term Winners. Not sure how many Big Pharma watch PAA but do know Big Pharma look toward Institutes of reputation like Leiden.

Last week Leiden completed a webinar regarding Covid , several thousand Medical Specialists attended from around the world. I see once PAA have completed an ASX announcement then Leiden will publish the results on behalf of the University...

June is nearly upon us ,, and todays trading must have taken the barnacles off the bottom.

Best of Luck NZT